Moderate mitral regurgitation in patients undergoing CABG - The MoMIC trial

Scandinavian Cardiovascular Journal

Volumn 43, Issue 1, 2009, Pages 50-56

  Wierup, Per ^a   Egeblad, Henrik ^a   Nielsen, Sten Lyager ^a   Scherstén, Henrik ^b   Kimblad, Per Ola ^c   Bech Hansen, Odd ^b   Roijer, Anders ^c   Nilsson, Folke ^b   McCarthy, Patrick M ^d   Bouchard, Denis ^e   Jacobsen, Jacob ^a   Johnsen, Søren Paaske ^a   Poulsen, Steen Hvitfeldt ^a   Mølgaard, Henning ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d NORTHWESTERN UNIVERSITY   (United States)

^e MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Ischemia; Mitral; Regurgitation; Surgery; Trial

Indexed keywords

BUMETANIDE; FUROSEMIDE; THIAZIDE DIURETIC AGENT; TORASEMIDE;

ADULT; AORTA VALVE DISEASE; ARTICLE; ASCENDING AORTA; CALCIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; SURVIVAL RATE;

BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; HEART FAILURE; HOSPITALIZATION; HUMANS; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL ISCHEMIA; NORTH AMERICA; RESEARCH DESIGN; SCANDINAVIA; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 61649094298     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430802430950     Document Type: Article

References (20)

1. Hickey MS, Smith LR, Muhlbaier LH, Harrell FE, Jr, Reves JG, Hinohara T, et al. Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation. 1988;78 (3 Pt 2):I51-9.
2. Wierup P, Lyager Nielsen S, Egeblad H, Scherstèn H, Kimblad P-O, Bech-Hansen O, et al. The prevalence of moderate mitral regurgitation in patients undergoing CABG. Scand Cardiovasc J. 2008;43:46-9.
3. Lamas GA, Mitchell GF, Flaker GC, Smith SC, Jr, Gersh BJ, Basta L, et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation. 1997;96:827-33.
4. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759-64.
5. Lancellotti P, Gerard PL, Pierard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J. 2005;26:1528-32.
6. Adler DS, Goldman L, O'Neil A, Cook EF, Mudge GH, Jr, Shemin RJ, et al. Long-term survival of more than 2,000 patients after coronary artery bypass grafting. Am J Cardiol. 1986;58:195-202.
7. Duarte IG, Shen Y, MacDonald MJ, Jones EL, Craver JM, Guyton RA. Treatment of moderate mitral regurgitation and coronary disease by coronary bypass alone: Late results. Ann Thorac Surg. 1999;68:426-30.
8. Sergeant P, Blackstone E, Meyns B. Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG. K.U. Leuven Coronary Surgery Program. Eur J Cardiothorac Surg. 1997;12:1-19.
9. Schroder JN, Williams ML, Hata JA, Muhlbaier LH, Swaminathan M, Mathew JP, et al. Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting. Circulation. 2005;112(9 Suppl):I293-8.
10. Paparella D, Mickleborough LL, Carson S, Ivanov J. Mild to moderate mitral regurgitation in patients undergoing coronary bypass grafting: Effects on operative mortality and long-term significance. Ann Thorac Surg. 2003;76:1094-100.
11. Balu V, Hershowitz S, Zaki Masud AR, Bhayana JN, Dean DC. Mitral regurgitation in coronary artery disease. Chest. 1982;81:550-5.
12. Chaffin JS, Daggett WM. Mitral valve replacement: A nine-year follow-up of risks and survivals. Ann Thorac Surg. 1979;27:312-9.
13. Cohn LH, Couper GS, Kinchla NM, Collins JJ, Jr. Decreased operative risk of surgical treatment of mitral regurgitation with or without coronary artery disease. J Am Coll Cardiol. 1990;16:1575-8.
14. Radford MJ, Johnson RA, Buckley MJ, Daggett WM, Leinbach RC, Gold HK. Survival following mitral valve replacement for mitral regurgitation due to coronary artery disease. Circulation. 1979;60 (2 Pt 2):39-47.
15. Christenson JT, Simonet F, Bloch A, Maurice J, Velebit V, Schmuziger M. Should a mild to moderate ischemic mitral valve regurgitation in patients with poor left ventricular function be repaired or not? J Heart Valve Dis. 1995;4:484-8.
16. Czer LS, Maurer G, Bolger AF, DeRobertis M, Chaux A, Matloff JM. Revascularization alone or combined with suture annuloplasty for ischemic mitral regurgitation. Evaluation by color Doppler echocardiography. Tex Heart Inst J. 1996;23:270-8.
17. Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M, Lauer MS, Gillinov AM, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49:2191-201.
18. Lam BK, Gillinov AM, Blackstone EH, Rajeswaran J, Yuh B, Bhudia SK, et al. Importance of moderate ischemic mitral regurgitation. Ann Thorac Surg. 2005;79:462-70.
19. Carpentier A. Cardiac valve surgery-the "French correction". J Thorac Cardiovasc Surg. 1983;86:323-37.
20. Bargiggia GS, Tronconi L, Sahn DJ, Recusani F, Raisaro A, De SS, et al. A new method for quantitation of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice. Circulation. 1991;84:1481-9.